Cucurbitacin B Diminishes Metastatic Behavior of Cholangiocarcinoma Cells by Suppressing Focal Adhesion Kinase.
Putthaporn KaewmeesriVeerapol KukongviriyapanAuemduan PrawanSarinya KongpetchLaddawan SenggunpraiPublished in: Asian Pacific journal of cancer prevention : APJCP (2021)
FAK participated in regulation of metastatic behavior of KKU-452 CCA cells. Cucurbitacin B suppressed FAK activation in the cells which was associated with inhibition of metastasis essential steps and their related metastatic proteins. The compound may be developed as a novel therapeutic agent for CCA metastasis therapy.<br />.